(Q83119894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The use of Campath in severe peripheral ulcerative keratitis associated with Wegener's granulomatosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

M S Wertheim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A H Ross

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D M Tole

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

7 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1453-1454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16601745%20AND%20SRC:MED&resulttype=core&format=json

Ocular complications of Wegener's granulomatosis

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021

Campath-1H therapy in refractory ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021

How do monoclonal antibodies induce tolerance? A role for infectious tolerance?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021

Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702330

7 January 2021